Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
This grant supports developing non-invasive imaging to measure how topical drugs penetrate the skin, aiming for a new way to test topical drug bioequivalence.
Funder: Food and Drug Administration
Due Dates: Forecasted (no due date posted)
Funding Amounts: $250,000 (single award; cooperative agreement)
Summary: Supports research to develop non-invasive imaging technologies for measuring topical drug penetration in skin, aiming to enable new methods for demonstrating bioequivalence of topical products.
Key Information: This is a forecasted opportunity; application details and deadlines are not yet posted.
Description
This funding opportunity from the Food and Drug Administration (FDA) aims to support research and development of non-invasive, tomography-based technologies to evaluate the pharmacokinetics of topically applied drug products in the skin. The goal is to develop accurate, sensitive, and reproducible methods and apparatus that can rapidly measure the amount of drug present at various depths within the skin in vivo, enabling serial monitoring over time. The ultimate intent is to create a scientifically valid, in vivo cutaneous pharmacokinetic approach that can efficiently demonstrate the bioequivalence of topical drug products, providing an alternative to current methods.
